Your basket is currently empty!
Global SARS-CoV-2 Expert Symposium 2022
Global SARS-CoV-2 Expert Symposium 2022
get the latest research insights on molecular and cellular immune responses to SARS-CoV-2 presented by leading groups around the world
On-Line Event, Thursday, 24 March 2022
12:50pm (GMT) / 8:50am (ET) / 8:50pm (GMT+8)
Register for Free Today
Via Email or LinkedIn
Following last year’s ProImmune SARS-CoV-2 Expert Symposium which attracted more than 1000 scientists, we are delighted to announce the next meeting in this exceptional series.
By participating in this half-day symposium, you will be inspired by renowned global experts presenting their SARS-CoV-2 research and discussing their latest insights and what they perceive to be the main challenges still to be overcome in this pandemic.
With new variants such as Omicron emerging, it is unknown whether or not the current approved vaccine designs will be sufficient to see us through to the end of the pandemic phase of SARS-CoV-2. In this meeting our expert speakers present and discuss key new advancements in our understanding of the molecular and cellular immune response to SARS-CoV-2 and SARS-CoV-2 vaccines as well as novel therapeutic interventions for populations at risk. Don’t miss your chance to hear first hand about these developments and participate in our moderated panel discussion.
Final Program
| GMT | ET | GMT+8 | Experts | Talk Title | |
|---|---|---|---|---|---|
| 12:50pm | 8:50am | 8:50pm | WELCOME | ||
| 1:00pm | 9:00am | 9:00pm |  | Dr. Jennifer Juno Research Officer, University of Melbourne, Australia | Establishment and recall of SARS-CoV-2 spike epitope-specific CD4+ T cell memory |
| 1:20pm | 9:20am | 9:20pm |  | Prof. William Liu Jun Deputy Director, Chinese National Influenza Center, China | Seeing the antiviral T cell immunity: believing the epitope based vaccines |
| 1:40pm | 9:40am | 9:40pm |  | Dr. Leo Swadling Research Fellow, University College London, UK | Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2 infection |
| 2:00pm | 10:00am | 10:00pm |  | Prof. Nikolai Petrovsky Research Director, Vaxine, Australia | Covax19/Spikogen®; the first approved recombinant spike protein vaccine |
| 2:20pm | 10:20am | 10:20pm |  | Moderator Prof. Antonio Bertoletti Principal Investigator, Duke-NUS, Singapore | Experts Panel Discussion Session 1 1. Prof. William Liu Jun 2. Prof. Nikolai Petrovsky 3. Dr. Jennifer Juno 4. Dr. Leo Swadling |
| 2:50pm | 10:50am | 10:50pm | NETWORKING BREAK | ||
| 3:20pm | 11:20am | 11:20pm |  | Mr. Edmund Neo ProImmune, Singapore | Epitope identification and clinical immune monitoring tools |
| 3:30pm | 11:30am | 11:30pm |  | Dr. Nawamin Pinpathomrat Senior Lecturer, Prince of Songkla University, Thailand | Immunogenicity and safety of an intradermal ChAdOx1 nCoV-19 boost in healthy general population |
| 3:50pm | 11:50am | 11:50pm |  | Prof. Marcus Buggert Group Leader, Karolinska Institute, Sweden | SARS-CoV-2-specific T cell responses in healthy and immunodeficient patients |
| 4:10pm | 12:10pm | 12:10am (+1) |  | Prof. Paul Klenerman Principal Investigator, Oxford University, UK | PITCH: Covid-19 immunity studies in a UK Health Care Worker Cohort |
| 4:30pm | 12:30pm | 12:30am (+1) |  | Moderator Dr. Jeremy Fry ProImmune, Oxford, UK | Experts Panel Discussion Session 2 1. Prof. Stephen Kent 2. Prof. Marcus Buggert 3. Prof. Paul Klenerman 4. Dr. Nawamin Pinpathomrat |
 | Expert Pannelist Prof. Stephen Kent Professorial Fellow, University of Melbourne, Australia | Find out more about Prof. Kent's breakthrough work in SARS-CoV-2 research |
|||
| 5:00pm | 1:00pm | 1:00am (+1) | CLOSING | ||
Previous SARS-CoV-2 Expert Symposium
Presentations from our meetings are available online free of charge.
 Dr. Kate Broderick, Inovio Pharmaceuticals |  Prof. Tao Dong, University of Oxford |  Prof. Alessandro Sette, University of California |  Prof. Katie Ewer, University of Oxford |
 Prof. Eui-Cheol Shin, KAIST |  Prof. Antonio Bertoletti, Duke-NUS |  Dr. Nina Le Bert, Duke-NUS |  Dr. Yanchun Peng, University of Oxford |
How will I benefit?
Learn from the academic experts as they highlight their discoveries.
Share information with like-minded scientist from other groups and explore new opportunities for collaboration.
Discover fresh perspectives and novel ideas to combat the challenges in the rapidly changing field of immunology.
Connect with scientists from different part of the world with similar research interest.
Conference Enquiries:
Email: enquiries@proimmune.com
Telephone (toll free): USA & Canada +1 888 505 7765
Asia-Pacific, Australia & New Zealand Region: +65 8338 1853; incl. WhatsApp/WeChat/Kakao
All Other Countries: +44 870 042 7279